BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND RSPO3, Q9BXY4, THSD2, PWTSR, FLJ14440, CRISTIN1, ENSG00000146374, 84870
29 results:

  • 1. LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon cancer.
    Mehdawi LM; Ghatak S; Chakraborty P; Sjölander A; Andersson T
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998393
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling.
    Ter Steege EJ; Doornbos LW; Haughton PD; van Diest PJ; Hilkens J; Derksen PWB; Bakker ERM
    Cancer Lett; 2023 Aug; 568():216301. PubMed ID: 37406727
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Incidence and clinical significance of 491 known fusion genes in a large cohort of Japanese patients with colorectal cancer.
    Nanishi K; Hino H; Hatakeyama K; Shiomi A; Kagawa H; Manabe S; Yamaoka Y; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
    Int J Clin Oncol; 2023 Jun; 28(6):785-793. PubMed ID: 37022622
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand-dependent cancer Models.
    Phillips C; Bhamra I; Eagle C; Flanagan E; Armer R; Jones CD; Bingham M; Calcraft P; Edmenson Cook A; Thompson B; Woodcock SA
    Cancer Res Commun; 2022 Sep; 2(9):914-928. PubMed ID: 36922934
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Investigation of cell signalings and therapeutic targets in PTPRK-rspo3 fusion-positive colorectal cancer.
    Jeong JH; Yun JW; Kim HY; Heo CY; Lee S
    PLoS One; 2022; 17(9):e0274555. PubMed ID: 36129915
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic and transcriptomic analysis of Korean colorectal cancer patients.
    Jeon SA; Ha YJ; Kim JH; Kim JH; Kim SK; Kim YS; Kim SY; Kim JC
    Genes Genomics; 2022 Aug; 44(8):967-979. PubMed ID: 35751785
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
    Hashimoto T; Takayanagi D; Yonemaru J; Naka T; Nagashima K; Yatabe Y; Shida D; Hamamoto R; Kleeman SO; Leedham SJ; Maughan T; Takashima A; Shiraishi K; Sekine S
    Br J Cancer; 2022 Oct; 127(6):1043-1050. PubMed ID: 35715628
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive genetic characterization of rectal cancer in a large cohort of Japanese patients: differences according to tumor location.
    Hino H; Shiomi A; Hatakeyama K; Kagawa H; Manabe S; Yamaoka Y; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
    J Gastroenterol; 2022 Jul; 57(7):476-485. PubMed ID: 35449312
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in colorectal cancer.
    Seeber A; Battaglin F; Zimmer K; Kocher F; Baca Y; Xiu J; Spizzo G; Novotny-Diermayr V; Rieder D; Puccini A; Swensen J; Ellis M; Goldberg RM; Grothey A; Shields AF; Marshall JL; Weinberg BA; Sackstein PE; Lim KH; Tan GS; Nabhan C; Korn WM; Amann A; Trajanoski Z; Berger MD; Lou E; Wolf D; Lenz HJ
    Clin Cancer Res; 2022 May; 28(9):1863-1870. PubMed ID: 35254413
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular drivers of tumor progression in microsatellite stable APC mutation-negative colorectal cancers.
    Grant A; Xicola RM; Nguyen V; Lim J; Thorne C; Salhia B; Llor X; Ellis N; Padi M
    Sci Rep; 2021 Dec; 11(1):23507. PubMed ID: 34873211
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The role of R-spondin proteins in cancer biology.
    Ter Steege EJ; Bakker ERM
    Oncogene; 2021 Nov; 40(47):6469-6478. PubMed ID: 34663878
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast cancers.
    Conboy CB; Vélez-Reyes GL; Rathe SK; Abrahante JE; Temiz NA; Burns MB; Harris RS; Starr TK; Largaespada DA
    DNA Cell Biol; 2021 Jan; 40(1):70-79. PubMed ID: 33320737
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
    Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
    Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansion.
    Boone PG; Rochelle LK; Ginzel JD; Lubkov V; Roberts WL; Nicholls PJ; Bock C; Flowers ML; von Furstenberg RJ; Stripp BR; Agarwal P; Borowsky AD; Cardiff RD; Barak LS; Caron MG; Lyerly HK; Snyder JC
    Nat Commun; 2019 Dec; 10(1):5490. PubMed ID: 31792216
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. rspo3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.
    Mesci A; Lucien F; Huang X; Wang EH; Shin D; Meringer M; Hoey C; Ray J; Boutros PC; Leong HS; Liu SK
    J Transl Med; 2019 Apr; 17(1):125. PubMed ID: 30987640
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. EIF3E-RSPO2 and PIEZO1-RSPO2 fusions in colorectal traditional serrated adenoma.
    Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Saito Y; Sekine S
    Histopathology; 2019 Aug; 75(2):266-273. PubMed ID: 30916365
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Acquisition of WNT Pathway Gene Alterations Coincides With the Transition From Precursor Polyps to Traditional Serrated Adenomas.
    Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Saito Y; Sekine S
    Am J Surg Pathol; 2019 Jan; 43(1):132-139. PubMed ID: 30179900
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.